TLM Utility Nav

Putting on the Spectacles to see the Spectrum of MetALD

Description

In this session we are demystifying the new term - MetALD, by providing the definition, new diagnostics, and relevance to treatments for patients.  

Journey Maps

Presentations

5:00 PM - 5:20 PM
Nov 17 2024
San Diego, CA

MetALD from direction of SLD (Focus on thresholds)

Mary Rinella, MD, FAASLD, Presenter
Patient Program
5:20 PM - 5:40 PM
Nov 17 2024
San Diego, CA

MetALD from direction of ALD (Data on binge drinking)

Juan Pablo Arab, MD, FRCPC, Presenter
Patient Program
5:40 PM - 6:10 PM
Nov 17 2024
San Diego, CA

Abstract Tour, w/focuses on MetALD, ALD re: SDOH

Suthat Liangpunsakul, MD, MPH, FAASLD, Presenter
Patient Program
6:10 PM - 6:20 PM
Nov 17 2024
San Diego, CA

Panel Discussion, Touching on SDOH and other Questions

Donna J Kincaid, Presenter
Patient Program
6:20 PM - 6:30 PM
Nov 17 2024
San Diego, CA

Panel Discussion, Touching on SDOH and other Questions

Jenn Jones, Presenter
Patient Program

Objectives

  • To understand the difference between MetALD and ALD definition
  • To review new diagnostic biomarkers related to MetALD
  • To enumerate treatment approaches for people with MetALD
Chair

Norah Terrault, MD, MPH, FAASLD

University of Southern California